Ignite Creation Date:
2025-12-24 @ 1:28 PM
Ignite Modification Date:
2026-01-02 @ 7:38 AM
Study NCT ID:
NCT00388895
Status:
COMPLETED
Last Update Posted:
2008-11-19
First Post:
2006-10-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Glivec in Ph Positive Lymphoblastic Leukemia
Sponsor:
PETHEMA Foundation
Organization:
Study Overview
Official Title:
Positive Ph Acute Lymphoblastic Leucemia With Intensive Induction Chemotherapy and Glivec, Before and After the Hematopoetic Progenitor Transplant
Status:
COMPLETED
Status Verified Date:
2008-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
% positive Ph LLA with RC alter the Glivec and induction chemotherapy treatment
Detailed Description:
Pilot phase II clinical trial, prospective, multicentric and opened
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| 02-0207 (nº AEMPS) | None | None | View |